Intech Biopharm Ltd. engages in the development of drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease. Its products include HFA metered dosage inhaler; respiratory drugs; and oncology drugs. The company was founded on October 28, 2010 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company